Bioactivity | Pep63 is a neuroprotective peptide (VFQVRARTVA). Pep63 has a neuroprotective effect on synaptic plasticity and memory. Pep63 can competitively bind with Aβ1-42 oligomers, and can block Aβ fiber formation. Pep63 can be used for Alzheimer’s disease (AD) research[1]. |
In Vivo | Pep63 可通过立体定向给药至背部海马,有效阻断 EphB2-ADDLs (Aβ 衍生的可扩散配体)的相互作用,并逆转早期 AD 小鼠模型中的记忆障碍[1]。转铁蛋白脂质体 (Transferrin-liposome) 是一种载体,可通过转铁蛋白受体 (TfR) 介导的转胞吞作用将 Pep63 递送至大脑[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
CAS | 1781242-18-9 |
Sequence | Val-Phe-Gln-Val-Arg-Ala-Arg-Thr-Val-Ala |
Shortening | VFQVRARTVA |
Formula | C51H87N17O13 |
Molar Mass | 1146.34 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Yang X, et al. Transferrin-Pep63-liposomes accelerate the clearance of Aβ and rescue impaired synaptic plasticity in early Alzheimer's disease models. Cell Death Discov. 2021 Sep 21;7(1):256. |